Saudi Araabia - inglise - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

bioveta a.s., czech republic - natrii citras anhydricus, natrii acetas anhydricus, natrii propionas, kalii chloridum, natrii chloridum, kalii dihydrogenophosphas - oral powder - 1.36.4.68.2.98.1.92.3.28 g

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

silver star brands - potassium sulfate (unii: 1k573lc5tv) (potassium cation - unii:295o53k152), ferrosoferric phosphate (unii: 91gqh8i5f7) (ferrosoferric phosphate - unii:91gqh8i5f7), sodium phosphate, dibasic (unii: gr686lba74) (phosphate ion - unii:nk08v8k8hr) - uses*: homeopathic remedy for relieving symptoms of bladder problems. *claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated. relieves burning sensation frequent urination & urgency.

Armeenia - inglise - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

krka d.d. - liquid aqueous cowslip root extract, liquid aqueous garden thyme herb extract - syrup - 1030mg/5ml+ 2060mg/5ml

Iirimaa - inglise - HPRA (Health Products Regulatory Authority)

fresenius kabi limited - potassium chloride; glucose monohydrate - solution for infusion - 0.15 + 5 percent weight/volume - solutions affecting the electrolyte balance; electrolytes with carbohydrates - blood substitutes and perfusion solutions; electrolytes with carbohydrates - prevention and treatment of potassium depletion and/or hypokalaemia in cases where supply of water and carbohydrates is required due to either restriction of the intake of fluids and electrolytes or depletion by normal routes

Iirimaa - inglise - HPRA (Health Products Regulatory Authority)

fresenius kabi limited - potassium chloride; glucose monohydrate - solution for infusion - 0.3 + 5 percent weight/volume - solutions affecting the electrolyte balance; electrolytes with carbohydrates - blood substitutes and perfusion solutions; electrolytes with carbohydrates - prevention and treatment of potassium depletion and/or hypokalaemia in cases where supply of water and carbohydrates is required due to either restriction of the intake of fluids and electrolytes or depletion by normal routes.

Armeenia - inglise - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

"kpe" zdorovye narodu" llc - tramadol (tramadol hydrochloride) - solution for injection - 50mg/ml

Singapur - inglise - HSA (Health Sciences Authority)

baxter healthcare (asia) pte ltd - cardiovascular - intended for repair of pericardial structures and for use as a prosthesis for the surgical repair of soft tissue deficiencies, which include: defects of the abdominal and thoracis wall, hernias (including diaphragmatic, femoral, incisional, inguinal, lumbar, paracolostomy, scrotal, and umbilical) and intracardiac and great vessel repair.

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

almatica pharma llc - gabapentin (unii: 6cw7f3g59x) (gabapentin - unii:6cw7f3g59x) - gralise is indicated for the management of postherpetic neuralgia. gralise is not interchangeable with other gabapentin products because of differing pharmacokinetic profiles that affect the frequency of administration. gralise is contraindicated in patients with demonstrated hypersensitivity to the drug or its ingredients. pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to gabapentin, including gralise, during pregnancy. encourage women who are taking gralise during pregnancy to enroll in the north american antiepileptic drug (naaed) pregnancy registry by calling the toll free number 1-888-233-2334 or visiting https://www.aedpregnancyregistry.org/. risk summary available data from published prospective and retrospective cohort studies, and case reports over decades of use with gabapentin during pregnancy have not identified a drug-associated risk of major birth defects. the avai

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

prasco laboratories - aliskiren hemifumarate (unii: c8a0p8g029) (aliskiren - unii:502fwn4q32) - aliskiren is indicated for the treatment of hypertension in adults and in pediatric patients weighing 50 kg or greater who are at least 6 years of age and older to lower blood pressure. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes. there are no controlled trials demonstrating risk reduction with aliskiren. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than 1 drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program’s joint national committee on prevention, detection,